Status:
COMPLETED
Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support
Lead Sponsor:
University of Zagreb
Conditions:
Luteal Phase Defect
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to compare efficacy and tolerability of the dydrogesterone and the vaginal progesterone, used for luteal phase support. (Initial start date was January 2009 but not for p...
Detailed Description
The use of gonadotropin-releasing hormone (GnRH) agonists in the ovarian stimulation, which prevents a premature surge of luteal hormone (LH), ultimately leads to suppression of the pituitary gland an...
Eligibility Criteria
Inclusion
- routine ovulation induction protocol with GnRH agonist
- less than three prior IVF cycles
- at least three aspirated oocytes
- BMI \<35 kg/m2
- age \<45 years
Exclusion
- history of dysfunctional uterine bleeding
- acute urogenital disease
- recurrent miscarriage
- previous allergic reactions to a progesterone products
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
853 Patients enrolled
Trial Details
Trial ID
NCT01178931
Start Date
October 1 2010
End Date
December 1 2013
Last Update
January 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Center Sisters of Mercy
Zagreb, Croatia, 10000